Mastracci Tara M, Greenberg Roy K
Endovascular and Vascular Surgery, The Cleveland Clinic Foundation, Cleveland, Ohio, USA.
J Vasc Surg. 2008 Dec;48(6 Suppl):17S-23S; discussion 23S. doi: 10.1016/j.jvs.2008.09.010.
Complex aortic disease continues to have a high mortality and morbidity despite advances in medical and surgical treatment. Repair of thoracoabdominal aneurysms, treatment of patients with connective tissue disorders, and the approach to dissections of the ascending and descending aorta have evolved over time; however, the results of intervention in all but highly specialized centers remain poor. As vascular surgeons, our role must extend beyond that of the pure technician; we have been vested with the life-long care of these patients and, therefore, have a responsibility to the patient in addition the scientific community and society at large to create a strategy for management that serves all three interests justly. We will outline some of the changes in the conceptual approach that we consider important to the treatment of complex aortic disease.
尽管在医学和外科治疗方面取得了进展，但复杂主动脉疾病的死亡率和发病率仍然很高。胸腹主动脉瘤的修复、结缔组织疾病患者的治疗以及升主动脉和降主动脉夹层的处理方法都随着时间的推移而不断演变；然而，除了高度专业化的中心外，其他地方的干预结果仍然很差。作为血管外科医生，我们的角色必须超越单纯技术人员的范畴；我们肩负着对这些患者的终身护理责任，因此，除了科学界和整个社会之外，我们对患者也负有责任，要制定一种公正地兼顾所有三方利益的管理策略。我们将概述一些我们认为对复杂主动脉疾病治疗很重要的概念性方法的变化。
